Related Experiment Video
Updated: Jun 19, 2026
07:38
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
PLASMA ESTERASE ACTIVITY IN PATIENTS WITH LIVER DISEASE AND THE NEPHROTIC SYNDROME.
1Hospital of The Rockefeller Institute for Medical Research.
The Journal of Experimental Medicine
|October 30, 2009
Summary
This study investigated plasma esterase in hypoproteinemia, finding liver disease impairs albumin synthesis. Nephrotic syndrome patients may lack albumin, not have liver abnormalities, for protein synthesis defects.
Area of Science:
- Biochemistry
- Clinical Medicine
- Hepatology
Background:
- Hypoproteinemia involves low protein levels in the blood.
- Plasma esterase levels can reflect liver function and protein synthesis.
- Albumin is a key protein synthesized by the liver.
Purpose of the Study:
- To investigate the role of plasma esterase in hypoproteinemic states.
- To understand the relationship between plasma esterase and albumin synthesis.
- To differentiate the causes of protein synthesis defects in liver disease versus nephrotic syndrome.
Main Methods:
- Studied plasma esterase levels in patients with infectious hepatitis, cirrhosis, and nephrotic syndrome.
- Correlated esterase levels with albumin levels and disease severity.
- Observed changes in esterase levels following therapy or remission.
Main Results:
- Infectious hepatitis and cirrhosis patients showed defective plasma esterase formation, paralleling albumin synthesis defects.
- Liver function improvement was necessary for protein synthesis normalization in cirrhosis.
- Nephrotic syndrome patients exhibited normal or high plasma esterase, with levels rising after remission or albumin administration.
Conclusions:
- Liver disease impairs protein synthesis due to liver dysfunction.
- Nephrotic syndrome's protein synthesis defect may stem from a lack of essential materials like albumin, not liver abnormality.
- Plasma esterase serves as a valuable indicator in differentiating causes of hypoproteinemia.
Related Concept Videos
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.